RIO DE JANEIRO, BRAZIL - The measure would benefit people administered doses of vaccines produced in China, such as Biotech's Sinovac, which in Brazil is called CoronaVac, as well as Sinopharm vaccines, and Russia's Sputnik V.
"I believe that this will have a favorable development. The assessment is underway and I believe that the concept of reciprocity between the states will be favorably considered. This is also important from a foreign policy perspective and not just from a vaccine standpoint," Magrini said during a medical meeting in the country.
This is not the first time that officials from government . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here